60 X 500 mg Capsules
Cautions and Contraindications
- EGCG blocked bortezomib’s antitumor effects at levels that are commonly achieved with the use of available concentrated green tea supplements (as low as 2.5 μM – which can be attained with two to three 250 mg capsules of green tea extract) suggesting the impact is very real for patients supplementing their therapy. Bortezomib is a proteasome inhibitor. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.
- Prolonged green tea extract (GTE) supplementation dramatically increased hepatic oxidative stress, inflammation and liver injury, and altered the bile acid synthesis pathway in mice fed a high cholesterol diet (HCD).